Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial (Q46911236)
Jump to navigation
Jump to search
scientific article published on 13 September 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial |
scientific article published on 13 September 2013 |
Statements
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial (English)
Robert Landewé
1 reference
Paul Wordsworth
Dominique Baeten
Xenofon Baraliakos
Jürgen Braun
Joachim Sieper
Jacob M van Laar
Jürgen Wollenhaupt
Herbert Kellner
Jacqueline Paramarta
Jiawei Wei
Arndt Brachat
Stephan Bek
Didier Laurent
Yali Li
Ying A Wang
Arthur P Bertolino
Sandro Gsteiger
Andrew M Wright
Wolfgang Hueber
13 September 2013
382
9906
1705-1713